Mark Stetter
Effective May 21, 2025, Dr. Mark Stetter was elected to the Board of Directors of the company at the Annual Meeting.
Highest-materiality recent filing
Zoetis declares Q3 2026 dividend of $0.53 per share
Quarterly dividend set at $0.53 per share for Q3 2026.
Zoetis Q1 revenue flat organic; cuts FY 2026 guidance on softer demand and competition
Revenue $2.3B, +3% reported but flat organic; net income $601M ($1.42 EPS), flat YoY.
Zoetis Q4 2025 revenue $2.4B (+3%), EPS $1.37; FY26 guidance $9.825-10.025B
Q4 2025 revenue $2.4B (+3% reported, +4% organic); net income $603M (EPS $1.37, +6%).
Zoetis declares Q2 2026 dividend of $0.53 per share
Dividend of $0.53 per share declared for second quarter of 2026.
Zoetis issues $2B of 0.25% convertible notes due 2029; proceeds for stock buyback and capped calls
Aggregate principal $2.0B (including $250M option exercised); 0.25% semi-annual interest; matures June 15, 2029.
Zoetis declares $0.53 per share quarterly dividend for Q1 2026
Zoetis declared a quarterly dividend of $0.53 per share for Q1 2026.
Zoetis posts Innovation Webcast presentation; no material financial details provided
Innovation Webcast scheduled for Dec 2, 2025 at 8:30 a.m. ET.
Zoetis Q3 adjusted EPS $1.70 (+8%); revenue $2.4B (+4% organic); FY guidance narrowed
Q3 revenue $2.4B (+1% reported; +4% organic operational); net income $721M, $1.63 diluted EPS (+9% YoY).
Zoetis appoints Stephanie Tilenius to Board, effective Dec 1, 2025
Stephanie Tilenius appointed to Zoetis Board, effective December 1, 2025.
Zoetis declares $0.50 per share Q4 dividend, payable Dec 2, 2025
Dividend of $0.50 per share declared for Q4 2025.
Zoetis enters $1.25B revolver, replaces 2022 facility; can increase to $1.75B
New five-year $1.25B senior unsecured revolving credit facility, maturing August 2030.
Zoetis issues $1.85B in senior notes: $850M at 4.150% due 2028, $1B at 5.000% due 2035
Issued $850M 4.150% Senior Notes due 2028 and $1B 5.000% Senior Notes due 2035.
Zoetis Q2 revenue $2.5B (+4% reported, +8% organic); raises FY2025 guidance
Reported net income $718M ($1.61 diluted EPS), up 15% YoY; adjusted EPS $1.76, up 13%.
Zoetis appoints Mark Stetter to board; Robert Scully retires
Robert Scully retired from Zoetis board effective May 21, 2025, under director retirement policy.
Zoetis declares $0.50/share quarterly dividend for Q3 2025
Dividend of $0.500 per share declared for third quarter 2025.
Effective May 21, 2025, Dr. Mark Stetter was elected to the Board of Directors of the company at the Annual Meeting.
Effective May 21, 2025, Mr. Robert Scully retired from the Board of Directors of Zoetis Inc.
Max materiality 0.75 · Median 0.45 · Most common event dividend